9Professor R. Schenk,P. Eggli,H. Fleisch,S. Rosini. Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat[J] 1986,Calcified Tissue International(6):342～349
6Pols HAP,Felsenberg D,Hanley DA,et al.Multinational,placebo-controlled,randomized trial of the ects of alendronate on bone density and fracture risk in poetmenopausal women with low bone mass:results of the FOSIT study[J].Osteoporos Int,1999,(9):461-468.
7Bell NH,Bilezikian JP,Bone HC,et al.Alendronate increases bone mass and reduces bone markers in postmenopausal African-American women[J].J Clin Endocrinol Metab,2002,(87):2792-2797.
8Graham DY.What the gastroenterologist should know about the gastrointestinal safety proles of bisphosphonates[J].Dig Dis Sci,2002,(47):1665-1678.
10Papapoulos SE, Quandt SA, Liberman UA, et al. Meta analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women [J]. Osteoporos Int, 2005, 16 (2): 468-474.
